10/7/2016 | BKCVHY | S&P downgrades PHH
|
4/12/2016 | BKCVHY | S&P downgrades PHH
|
4/11/2016 | BKCVHY | Moody’s reviews PHH
|
3/11/2016 | BKCVHY | Moody’s revises PHH to negative
|
3/10/2016 | BKCVHY | S&P lowers PHH to negative
|
6/16/2015 | CVLM | PHH exchanges 99.19% of 6% convertibles due 2017
|
6/15/2015 | CVLM | PHH sets exchange ratio in offer to exchange 6% convertibles due 2017
|
5/8/2015 | CV | Market Commentary: Fluidigm down outright, expands on swap after earnings; Nvidia in line on swap; PHH active
|
5/8/2015 | CV | Market Commentary: Morning Commentary: PHH extends gains on exchange offer; Nvidia drops outright, in line on swap
|
5/7/2015 | CV | Market Commentary: New Anthem adds after upsizing; HeartWare, PHH trade on exchange offers; HeartWare prices
|
5/6/2015 | CVLM | PHH begins exchange offer for 6% convertible notes due 2017
|
7/8/2014 | CV | Market Commentary: Intel dominates trading volume; Qihoo, GT Advanced down outright, unchanged on hedge
|
7/8/2014 | BKCVHY | S&P cuts PHH to B+
|
7/8/2014 | BKCVHY | Moody’s downgrades PHH
|
7/8/2014 | BKCVHY | Fitch gives PHH negative outlook
|
6/4/2014 | BKCVHY | Moody's might cut PHH
|
6/4/2014 | BKCVHY | Fitch downgrades PHH
|
3/12/2014 | BKCVHY | Moody's: PHH view to negative
|
2/12/2014 | BKCVHY | Fitch: PHH on evolving watch
|
2/10/2014 | CV | Market Commentary: AMAG Pharmaceuticals offers $150 million deal; Xilinx 3.125% notes steady; Medicines down
|
8/6/2013 | BKCVHY | S&P rates PHH notes BB-
|
8/6/2013 | BKCVHY | Fitch to rate PHH notes BB
|
8/1/2013 | CV | PHH says convertible notes due 2017 are now convertible as of June 30
|
5/28/2013 | BKCVHY | Fitch: PHH outlook to stable
|
4/17/2013 | BKCVHY | Moody's lifts PHH to stable
|
4/1/2013 | BKCVHY | S&P lifts PHH view to stable
|
2/11/2013 | CV | Market Commentary: New Molina upsizes; planned Molina, Starwood bid higher in gray; Regeneron 'comes in'
|
10/18/2012 | CV | Market Commentary: New Walter gains well on debut; Lam Research flat to 'in' slightly on hedge; MannKind down
|
8/10/2012 | BKCVHY | Fitch gives PHH notes BB
|
5/30/2012 | BKCVHY | Fitch lowers PHH
|
3/29/2012 | BKCVHY | S&P lowers PHH shelf
|
2/28/2012 | CV | Market Commentary: DealerTrack up in gray market ahead of final pricing; Stone Energy on tap; iStar higher
|
2/28/2012 | CVLM | PHH bought back $48 million of its convertible notes due April 2012
|
2/7/2012 | BKCVHY | PHH to focus on liquidity/balance sheet, pay 2012 and 2013 maturities
|
1/17/2012 | CV | PHH greenshoe exercised in full to lift convertibles to $250 million
|
1/12/2012 | CV | Market Commentary: Human Genome premium expands; new PHH extends gains; Petroplus, Sino-Forest in focus
|
1/11/2012 | CV | New Issue: PHH prices upsized $220 million 5.5-year convertibles at 6%, up 25%
|
1/11/2012 | CV | Market Commentary: New PHH surges out of the chute; existing PHH convertibles improve; NuVasive up on hedge
|
1/11/2012 | BKCVHY | Moody's: PHH view to negative
|
1/10/2012 | BKCVHY | Fitch places PHH on watch, rates notes BB+
|
1/10/2012 | BKCVHY | Moody's: PHH view negative
|
1/10/2012 | CV | PHH to sell $150 million 5.5-year convertibles at 5.5%-6%, up 25%-30%
|
1/10/2012 | CV | Market Commentary: PHH's existing convertibles steady to higher on new deal launch; Kodak paper improves
|
1/4/2012 | BKCVHY | S&P: PHH unaffected
|
12/23/2011 | CV | Market Commentary: SunPower jumps on Total transactions; PHH slips further; market quiet ahead of holiday
|
12/22/2011 | CV | Market Commentary: PHH drops sharply on S&P ratings cut; Micron recoups early losses; SandRidge in focus
|
12/22/2011 | BKCVHY | S&P downgrades PHH
|
12/20/2011 | BKCVHY | S&P places PHH on watch
|
11/30/2011 | BKCVHY | Fitch rates PHH notes BB+
|
10/11/2011 | CV | Market Commentary: Convertibles 'better to buy'; New issue market welcomes new United Therapeutics paper
|
8/1/2011 | BKCVHY | Fitch affirms PHH
|
3/24/2011 | BKCVHY | S&P ups PHH view to stable
|
1/12/2011 | CV | Market Commentary: Hedged holders lose on Teva call; Nielsen mandatory to price Jan. 24 week; GM mandatory up
|
8/4/2010 | BKCVHY | Fitch rates PHH notes BB+
|
8/3/2010 | CV | Market Commentary: Teleflex adds slightly in gray market, prices; MGM strengthens; PHH gains after debt issue
|
7/7/2010 | BKCVHY | Fitch affirms PHH
|
6/30/2010 | CVHY | Moody's affirms PHH
|
10/13/2009 | CV | Market Commentary: Convertibles mostly quiet again; airlines trade; Avis remains firm; PHH, Gaylord below par
|
10/5/2009 | CV | Market Commentary: UAL adds amid quiet trading; AMD gains; Medtronic up in solid volume; trading breadth narrow
|
9/29/2009 | CV | PHH Corp. greenshoe exercised, raising convertibles to $250 million
|
9/29/2009 | CV | Market Commentary: Convertibles still quiet; some sellers step in; AMR, PHH better; Kodak lower; Nasdaq dips
|
9/25/2009 | CV | Market Commentary: Incyte trades up smartly on debut; AMR steady to stronger; Gaylord, PHH tracking over par
|
9/24/2009 | CV | Market Commentary: Gaylord, PHH, ATP Oil slip from highs with stocks; Incyte looks less cheap as terms reset
|
9/23/2009 | CV | New Issue: PHH sells upsized $220 million five-year convertibles at 4%, up 30%
|
9/23/2009 | CV | Market Commentary: AMR, Goodrich Petroleum gain on debuts; Gaylord Entertainment, PHH price upsized deals
|
8/24/2009 | CVHY | Fitch affirms PHH
|
2/26/2009 | CVHYIG | Fitch cuts PHH to junk
|
2/11/2009 | CVHYIG | S&P cuts PHH to junk
|
12/16/2008 | CVIG | Fitch puts PHH on watch
|
12/8/2008 | CVIG | Moody's drops PHH senior unsecured
|
11/26/2008 | CVIG | PHH files $2 billion shelf registration
|
4/2/2008 | CV | PHH greenshoe fully exercised, lifts 4% convertibles due 2012 to $250 million
|
3/28/2008 | CV | Market Commentary: National City, REITS lower; Ford, Best Buy drop; but PHH gains in strong debut
|
3/28/2008 | CV | New Issue: PHH prices upsized $220 million four-year convertibles to yield 4%, up 20.59%
|
3/27/2008 | CV | PHH to price $150 million four-year convertibles to yield 3.75%-4.25%, up 17.5%-22.5%
|
3/27/2008 | CV | Market Commentary: Convertibles mostly quiet; On Semi adds a half; PHH gains in the gray; Entertainment Properties to price
|